Tus kws kho mob
QP74-23 Commercial Pharmacy Benefit Exclusion for Abilify Asimtufii®, Adstiladrin®, Brixadi™, Glydo®, lidocaine 2%, Roctavian™, and Uzedy™
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2141 - 2150 ntawm 4179
Tus kws kho mob
QP75-23 MHCP Pharmacy Benefit Exclusion for Adstiladrin®, Brixadi™, and Roctavian™
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tus kws kho mob
QP76-23 Commercial Pharmacy Benefit Exclusion for Sublocade®
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 13, 2023
Tus kws kho mob
P59-23 Services Removed from the Commercial Prior Authorization List
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P60-23 Home Health Agencies are Required to Provide Minnesota Home Care Bill of Rights for Clients
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P61-23 Inpatient Hospital Admission Prior Authorization Removed for Medicare Advantage; Pre-Admission Notification Required
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P62-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P63-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective November 6, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P65-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Radiation Oncology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P66-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2023